Levitex undergoes clinical trial to reinforce benefits of its pioneering pressure support surface
A newly-patented innovation called Levitex is aiming to revolutionise the healthcare market by providing customers with a versatile sleeping surface which can prevent pressure ulcers, improve neck and spine alignment, and ease neck and back pain.
Levitex was created by Manchester start-up Levitex Foams, a company which combines medical device engineering with postural management expertise, speciality chemical engineers and entrepreneurs.
The company says Levitex will disrupt the sleep market and have a “phenomenal” impact on people’s lives.
The support surface uses polyurethane foam technology and, according to the company, has achieved “outstanding” results in clinical trials and live studies.
Levitex underwent an independent clinical trial in June 2018 with the Directorate of Occupational Therapy at The University of Salford and has an eminent Medical Director in Dr Ilan Lieberman, who works as a Pain Medicine Consultant and Clinician with The University Hospitals of South Manchester (UHSM).
In the laboratory-based experimental study with The University of Salford, the aim was to investigate the interface pressures exhibited on 27 volunteers, aged 20-49, when using the Levitex support surface.
The results revealed that 100 percent of the participants found the Levitex foam mattress comfortable; the surface redistributed pressure effectively; and patients felt more relaxed.
Jo-anne Webb, Directorate of Occupational Therapy at University of Salford, commented: “Pressure sores are a common, costly and physically debilitating health problem, affecting people in both acute care and at home. The development of a pressure ulcer can impact on an individual’s rehabilitation process leading to extended hospital stays.”
Levitex is the brainchild of CEO and Postural Expert James Leinhardt, who strived to create positive change through his experience within the NHS.
The pressure surface addresses three vital factors that contribute to a better night’s sleep – posture, pressure and proprioception. Levitex says these three factors can vastly improve neck and spine alignment and prevent and ease neck and back pain.
To find out more about Levitex, visit the websitehttps://thiis.co.uk/levitex-undergoes-clinical-trial-to-reinforce-benefits-of-its-pioneering-pressure-support-surface/https://i1.wp.com/thiis.co.uk/wp-content/uploads/2019/09/Levitex-master.jpg?fit=1000%2C593&ssl=1https://i1.wp.com/thiis.co.uk/wp-content/uploads/2019/09/Levitex-master.jpg?resize=150%2C150&ssl=1NewsroomSupplier Newsclinical trial,healthcare market,Levitex,Levitex Foams,Pressure Care,pressure surface pressure redistribution,pressure ulcers,The University of SalfordA newly-patented innovation called Levitex is aiming to revolutionise the healthcare market by providing customers with a versatile sleeping surface which can prevent pressure ulcers, improve neck and spine alignment, and ease neck and back pain. Levitex was created by Manchester start-up Levitex Foams, a company which combines medical device...Sarah SarsbySarah Sarsbysarah@thiis.co.ukAdministratorTHIIS Magazine